CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

Abstract Background Triple negative breast cancer (TNBC) is aggressive with limited treatment options upon recurrence. Molecular discordance between primary and metastatic TNBC has been observed, but the degree of biological heterogeneity has not been fully explored. Furthermore, genomic evolution t...

Full description

Bibliographic Details
Main Authors: Zi-Ming Zhao, Susan E. Yost, Katherine E. Hutchinson, Sierra Min Li, Yate-Ching Yuan, Javad Noorbakhsh, Zheng Liu, Charles Warden, Radia M. Johnson, Xiwei Wu, Jeffrey H. Chuang, Yuan Yuan
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
Triple negative breast cancer
CCNE1
Amplification
Online Access:http://link.springer.com/article/10.1186/s12885-019-5290-4

Internet

http://link.springer.com/article/10.1186/s12885-019-5290-4

Similar Items